LISATA THERAPEUTICS, INC. (LSTA) — Institutional Holders, Q2 2026

33 institutional investment managers reported a LSTA position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $4.1M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

LSTA in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

3

Added to

9

Trimmed

6

Sold out

5

Biggest buyers

  1. Yakira Capital ManagementNew · +138,561 sh+$471.1K
  2. CSSAdded · +48,524 sh+$165.0K
  3. JANE STREET GROUPNew · +18,741 sh+$63.7K
  4. Virtu FinancialAdded · +16,569 sh+$56.3K
  5. VANGUARD FIDUCIARYAdded · +14,047 sh+$47.8K

Biggest sellers

  1. Deeter Investments LLPTrimmed · -245,608 sh-$835.1K
  2. RENAISSANCE TECHNOLOGIESSold out · -131,715 sh-$447.8K
  3. PenderFund Capital Management Ltd.Sold out · -47,500 sh-$161.5K
  4. SUSQUEHANNA INTERNATIONAL GROUP, LLPSold out · -11,604 sh-$39.5K
  5. CITADEL ADVISORSTrimmed · -7,125 sh-$24.2K

LSTA 13F holders ranked 1–33 of 33

Institutional investors reporting a position in LISATA THERAPEUTICS, INC. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
VANGUARD CAPITAL MANAGEMENT#1 · 278,837 sh$948.0K+2.6%
Yakira Capital Management#2 · 138,561 sh$471.1KNew
Deeter Investments LLP#3 · 118,871 sh$404.2K-67.4%
CSS#4 · 110,422 sh$375.4K+78.4%
DELTEC ASSET MANAGEMENT#5 · 83,197 sh$282.9K-7.6%
Rangeley Capital#6 · 81,000 sh$275.4K+8.0%
GEODE CAPITAL MANAGEMENT#7 · 72,632 sh$247.0K+2.5%
Virtu Financial#8 · 58,782 sh$200.0K+39.3%
BlackRock#9 · 54,857 sh$186.5K0.0%
VANGUARD FIDUCIARY#10 · 48,964 sh$166.5K+40.2%
GTS SECURITIES#11 · 30,200 sh$102.7K-3.8%
STATE STREET#12 · 25,348 sh$86.2K0.0%
JANE STREET GROUP#13 · 18,741 sh$63.7KNew
CITADEL ADVISORS#14 · 15,541 sh$52.8K-31.4%
NORTHERN#15 · 15,534 sh$52.8K+51.3%
JBF Capital#16 · 14,347 sh$48.8K+8.4%
Cerity Partners#17 · 12,183 sh$41.4K0.0%
BANK OF AMERICA#18 · 10,353 sh$35.2K0.0%
HighTower Advisors#19 · 10,042 sh$34.1K0.0%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT#20 · 5,000 sh$16.8K0.0%
Founders Capital Management#21 · 1,667 sh$5.7K0.0%
Vanguard Global Advisers#22 · 1,033 sh$3.5K0.0%
Connective Capital Management#23 · 1,016 sh$3.5K0.0%
Tower Research Capital (TRC)#24 · 726 sh$2.5K-7.5%
OSAIC#25 · 200 sh$680.000.0%
Caitong International Asset Management , Ltd#26 · 90 sh$306.00+309.1%
MORGAN STANLEY#27 · 75 sh$255.000.0%
BARCLAYS PLC#28 · 70 sh$238.00New
SBI Securities , Ltd.#29 · 7 sh$24.000.0%
Cheviot Value Management#30 · 3 sh$10.000.0%
Fortitude Family Office#31 · 1 sh$3.000.0%
ROYAL BANK OF CANADA#32 · 52 sh$0.00-99.1%
FMR#33 · 0 sh$0.00New

Funds that sold out of LSTA in Q2 2026 (5)

Held LSTA at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held LSTA in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
RENAISSANCE TECHNOLOGIES131,715 sh$659.9K
PenderFund Capital Management Ltd.47,500 sh$238.0K
SUSQUEHANNA INTERNATIONAL GROUP, LLP11,604 sh$58.1K
UBS Group AG1,909 sh$9.6K
CITIGROUP1 sh$5.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.